Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss (Q39139952)

9 September 2017

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss (English)

1 reference

9 September 2017

Hideyuki Arita

1

1 reference

9 September 2017

Yoshitaka Narita

2

1 reference

9 September 2017

Shintaro Fukushima

3

1 reference

9 September 2017

Kensuke Tateishi

4

1 reference

9 September 2017

Yuko Matsushita

5

1 reference

9 September 2017

Akihiko Yoshida

6

1 reference

9 September 2017

Yasuji Miyakita

7

1 reference

9 September 2017

Makoto Ohno

8

1 reference

9 September 2017

V Peter Collins

9

1 reference

9 September 2017

Nobutaka Kawahara

10

1 reference

9 September 2017

Soichiro Shibui

11

1 reference

9 September 2017

Koichi Ichimura

12

1 reference

9 September 2017

14 June 2013

1 reference

9 September 2017

Acta Neuropathologica

1 reference

9 September 2017

126

1 reference

9 September 2017

267-276

1 reference

9 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-013-1141-6

9 September 2017

0 references

cites work

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Alternative lengthening of telomeres: remodeling the telomere architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Prediction of clinical course of diffusely infiltrating astrocytomas from telomerase expression and quantitated activity level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

TERT promoter mutations in familial and sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Highly recurrent TERT promoter mutations in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Molecular pathogenesis of IDH mutations in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Telomerase activity in human brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Telomerase activity in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Telomerase and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

MGMT CpG island is invariably methylated in adult astrocytic and oligodendroglial tumors with IDH1 or IDH2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Novel anticancer therapeutics targeting telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Telomerase activity in 144 brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

Real-time quantitative polymerase chain reaction (qPCR) analysis with fluorescence resonance energy transfer (FRET) probes reveals differential expression of the four ERBB4 juxtamembrane region variants between medulloblastoma and pilocytic astrocyt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-013-1141-6

10.1007/S00401-013-1141-6

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference